SCHEMBL12501064

SCHEMBL12501064

Cn1cc(-c2cnc3c(ccn3-c3cn(S(=O)(=O)c4ccccc4)c4cnccc34)c2)cn1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 1/20 0.60
▸ MAPT P10636 2/20 0.46
▸ HTR6 P50406 7/20 0.40
▸ WNT1 P04628 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ FGFR1 P11362 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ PIK3C3 Q8NEB9 1/20 0.36
▸ CYP2C19 P33261 1/20 0.35
▸ CCNC P24863 1/20 0.35
▸ CDK8 P49336 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ RAPGEF4 Q8WZA2 1/20 0.35
▸ MET P08581 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3509001 0.81 CYP2C19 (0.51) PDPK1HTR6WNT1GSK3BDYRK1A
SCHEMBL12501057 0.75 PDPK1 (1.00) PDPK1
SCHEMBL2724221 0.71 BRD4 (0.62) PDPK1HTR6WNT1GSK3BDYRK1A
SCHEMBL3506020 0.71 PDPK1 (0.54) PDPK1HTR6WNT1GSK3BDYRK1A
SCHEMBL17759254 0.71 MET (0.51) PDPK1HTR6MAPK1AURKBMET
SCHEMBL17742865 0.70 PDPK1 (0.77) PDPK1HTR6DYRK1ACCNCCDK8
SCHEMBL2750994 0.69 PDPK1 (0.54) PDPK1HTR6FGFR1MET
SCHEMBL9280138 0.69 PDPK1 (0.49) PDPK1HTR6WNT1GSK3BDYRK1A
SCHEMBL21404588 0.68 HTR6 (0.49) PDPK1HTR6WNT1GSK3BDYRK1A
SCHEMBL30878062 0.68 HTR6 (0.49) PDPK1HTR6WNT1GSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2670748-A2 7-AZAINDOLE DERIVATIVES Merck Patent GmbH (DE) 2013-12-11 — — EP disclosed
WO-2012104007-A2 7-AZAINDOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-08-09 — — WO disclosed
Send feedback